Dactinomycin for Injection (box of 1 vial)
Dactinomycin for Injection (box of 1 vial)
*Packaging color may differ according to distribution region.

Dactinomycin for Injection

Dactinomycin for Injection is an antitumor antibiotic indicated for cancer chemotherapy. This pharmaceutical drug is manufactured by AdvaCare Pharma, using only high quality ingredients, in its ISO/GMP-approved production plants.



What is Dactinomycin?

Therapeutic Class:

Active Ingredients: Dactinomycin

Dactinomycin for Injection is an antineoplastic drug used in cancer chemotherapy. It is used to treat some solid tumors, such as Ewing sarcoma. This drug can be used alone or as a combination therapy to treat gestational trophoblastic neoplasia and recurrent or locoregional solid malignancies.

The active ingredient, Dactinomycin, is classified as an antitumor antibiotic. It works by slowing down or stopping the growth of cancer cells in the body by blocking topoisomerase 2, an enzyme needed by cancer cells.

Dactinomycin is also called “actinomycin D”.

AdvaCare Pharma is a producer and exporter of Dactinomycin for Injection. This medicine is produced in our GMP-certified facilities in China, India, and the USA. These facilities are routinely audited to ensure they comply with health, safety, and environmental standards.

Why choose us as your Dactinomycin manufacturer?

AdvaCare Pharma manufactures a variety of oncology medications, including Dactinomycin for Injection, at GMP-certified facilities. We are committed to producing cost-effective, high-quality cancer treatments that meet the highest industry standards and are readily available to cancer patients worldwide. Our global reach extends to over 65 markets, where we supply our products to distributors, hospitals, pharmacies, NGOs, and government institutions.


What is Dactinomycin used for?

It is used to treat cancer, either as a monotherapy or with other medications. Some of the types of cancer it can treat are:

  • Ewing sarcoma
  • metastatic nonseminomatous testicular carcinoma
  • rhabdomyosarcoma
  • trophoblastic neoplasms
  • Wilms' tumors

When combined with Methotrexate, this drug is used to treat gestational trophoblastic neoplasia.

How should Dactinomycin Powder be used?

This medication has been manufactured as a powder, which is stored in a vial. The powder is to be prepared into a solution, and after reconstitution, it should be administered by injection into a muscle or vein.

As Dactinomycin for Injection is a cytotoxic drug, caution should be used when preparing and administering the solution. Goggles, gloves, and protective gowns are recommended

What dose should be given?

For Wilms tumor, the usual dose is 45 mcg/kg IV as part of a multi-drug chemotherapy.

The usual dose for adults and children depends on the type of disease and the patient's general condition. Refer to a doctor or pharmacist for guidelines on dosage. Do not exceed what they advise.

Side Effects

As with all pharmaceuticals, some unwanted effects can occur from treatment with Dactinomycin for Injection. Always consult a doctor or healthcare professional for medical advice before beginning treatment.

Common side effects include, but may not be limited to:

Seek medical attention if the following develop:

  • darkening of the skin
  • nausea
  • vomiting
  • skin rash or acne
  • unusual weakness

For a comprehensive list of all possible effects, consult a doctor.

If any symptom persists or gets worse, or you notice any other symptoms, please call your doctor immediately.


Do NOT use Dactinomycin for Injection:

  • You have hypersensitivity to any component of this product.
  • You contract chickenpox or herpes zoster before you begin treatment.

The use of Dactinomycin during pregnancy or breastfeeding should be avoided, as Dactinomycin is harmful to the fetus or baby. Consult a doctor or healthcare professional before treatment.

Consult with your doctor about any medications you are taking before beginning treatment with Dactinomycin.

*Regulatory compliance may vary according to production standard, import requirements and/or manufacturing origin.

You might be interested in...

Methotrexate Injection (box of 1 vial)
Methotrexate Injection
Letrozole Tablets (box of 100 tablets)
Letrozole Tablets
Tamoxifen Tablets (box of 100 tablets)
Tamoxifen Tablets
Granisetron HCL Injection (box of 1 vial)
Granisetron HCL Injection
Anastrozole Tablets (box of 100 tablets)
Anastrozole Tablets
Exemestane Tablets (box of 30 tablets)
Exemestane Tablets
Ondansetron HCL Tablets (box of 100 tablets)
Ondansetron Tablets
Hydroxyurea Capsules (box of 100 capsules)
Hydroxyurea Capsules

Why AdvaCare Pharma?

As an industry leader, we are aware of our responsibility to provide affordable and sustainable solutions to improve healthcare worldwide.

High Quality Affordable Products
Globally Recognized Brands
Wide Product Range
Regulatory Affairs Expertise
Flexible Production Lines
Marketing & Logistics Support